HOME >> MEDICINE >> NEWS
Drug safety in the doctor's office: Nearly half of patients have lapses in monitoring

May 5, 2005 According to research published in the Journal of General Internal Medicine, only slightly more than half of patients taking chronic medications received the recommended laboratory tests to monitor drug side effects.

Annual or more frequent lab testing is recommended in patients who use certain medications on an ongoing basis so that drug complications can be avoided. However, these tests to monitor the safety of chronic medications are not performed as frequently as they should be. Prior research has indicated that as many as 60% of preventable drug complications were related to laboratory monitoring errors.

This study examined almost 100,000 patients taking medications for chronic illnesses over a period of three years to determine whether they received the recommended laboratory tests to monitor potential drug side effects. Nearly half of these patients (44-47% per year) did not receive one or more recommended tests, though it is important to note that the findings varied based on the type of drug,.

The researchers conclude that although lapses in drug safety monitoring in the outpatient setting are common, further research is needed to determine to what extent this failure to monitor results in actual medical problems. Drug safety monitoring is an important care issue that needs to be addressed by healthcare systems and physicians, and in physician practice guidelines.

Individuals who are prescribed a chronic medication can be proactive and ask their physicians what tests to monitor side effects are needed and how often, then call their physician for a laboratory referral when the time comes to be tested.


'"/>

Contact: Sharon Agsalda
medicalnews@bos.blackwellpublishing.net
781-388-8507
Blackwell Publishing Ltd.
5-May-2005


Page: 1

Related medicine news :

1. National quality agenda, payment reform, care integration keys to improving quality, patient safety
2. LSUHSC awarded designation resulting in improved patient safety and outcomes
3. New survey uncovers how insomnia affects job performance and safety
4. Extended duration work shifts risky to the safety, well-being of medical interns, patients
5. Efficacy and safety of Aripiprazole as adjunctive therapy in major depressive disorder
6. UW study to clarify safety, effectiveness of hormone therapy during menopause
7. Ulcerative colitis remission rates from long-term safety study of LIALDA presented at DDW
8. U of M faculty honored by US FDA for contributions to national food safety and defense
9. Hospital errors rise 3 percent -- HealthGrades patient-safety study
10. MERLIN TIMI-36 study provides new safety and efficacy data for unique anti-anginal therapy
11. Studies highlight real world use, safety of drug-eluting stents

Post Your Comments:
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Roughly four in ... obstructive pulmonary disease (COPD) actually do not have the ... issue: Faulty diagnoses were made based on an evaluation ... "gold standard" disease test known as spirometry, which shows ... the amount of air they can exhale and how ...
(Date:5/22/2013)... New research from Brigham and Women,s Hospital (BWH) finds ... uncommon but deadly lung disease, may be effective in ... findings will be presented at the American Thoracic Society ... New England Journal of Medicine on May 22 ... edition., "While this variant of the MUC5B gene is ...
(Date:5/22/2013)... ATS 2013, PHILADELPHIA ─More than 40 percent of ... funded clinic did not have the disease, researchers ... diagnostic "gold standard" for chronic obstructive pulmonary disease. ... the under-diagnosis of COPD, there has not been ... of over-diagnosis," said Christian Ghattas, MD., MSc, ...
(Date:5/22/2013)... In the past decade, more ... courts with donated uniforms, shoes, balls and other ... to partnering with manufacturers to provide youth with sporting ... $8.8 million in sports and fitness equipment over 10 ... outfitted for physical activity. , An inaugural donation ...
(Date:5/22/2013)... Alabama (PRWEB) May 22, 2013 ... solutions to state Health and Human Services and ... of Mental Health (ADMH) selected the CoCENTRIX ... platform to manage the Health Records and coordinate ... psychiatric hospitals. , CoCENTRIX is transitioning the ...
Breaking Medicine News(10 mins):Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Genetic marker associated with risk for pulmonary fibrosis 2Health News:Study finds COPD is over-diagnosed among uninsured patients 2Health News:Study finds COPD is over-diagnosed among uninsured patients 3Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 3
(Date:5/22/2013)... 22, 2013  Grifols, a global healthcare company based ... from a study demonstrating that a higher dose of ... levels of the alpha 1 protein in patients ... are considered within the normal range for healthy individuals. ... low levels of the alpha 1 proteinase inhibitor ...
(Date:5/22/2013)...  BD (Becton, Dickinson and Company) (NYSE: ... today the publication of its 2012 Sustainability Report ... continues to focus on the Company,s shared value approach ... of shared value — creating value for shareholders by ... are fundamental to our strategy," said Vincent ...
(Date:5/22/2013)... Calif. , May 22, 2013 Rigel ... the clinical advancement of three programs in development. The ... a JAK/SYK inhibitor, R348, being developed by Rigel as ... programs are aimed at oncology targets and are being ... under development by BerGenBio AS (BerGenBio) and a ligase ...
Breaking Medicine Technology:Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4
Cached News: